Serial 97127465
Live / Registered — Registered (as of 17 Mar 2026)
What this means for you
Registered since 17 Mar 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97127465
- Registration number
- 8178570
- Mark type
- Design / logo
- Filed
- 16 Nov 2021
- Published for opposition
- 13 Sept 2022
- Registered
- 17 Mar 2026
- Attorney of record
- Heather A. McDonald
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer and blood disorders
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 17 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
- 25 Feb 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Feb 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 11 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Feb 2026 — ASSIGNED TO LIE
- 05 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Oct 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 08 Oct 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 14 Aug 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 Aug 2025 — NON-FINAL ACTION E-MAILED
- 14 Aug 2025 — SU - NON-FINAL ACTION - WRITTEN
- 23 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jul 2025 — STATEMENT OF USE PROCESSING COMPLETE